Ads
related to: abbvie stock price
Search results
Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion
The Globe and Mail· 10 hours agoShares of drug developer Morphic surged 76 per cent to $56.15 premarket on Lilly’s offer of $57 per...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Reuters via Yahoo Finance Canada· 11 hours agoShares of Waltham, Massachusetts-based Morphic surged nearly 75% to $55.62 in morning trading on...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 6 days agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance Canada· 6 days agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 7 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...